A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis

Cancer Research

Volumn 67, Issue 7, 2007, Pages 3450-3460

  Alonso, Soledad R ^a   Tracey, Lorraine ^a   Ortiz, Pablo ^a   Pérez Gómez, Beatriz ^b   Palacios, José ^a   Pollán, Marina ^b   Linares, Juan ^c   Serrano, Salvio ^c   Sáez Castillo, Ana I ^c   Sánchez, Lydia ^a   Pajares, Raquel ^a   Sánchez Aguilera, Abel ^a   Artiga, Maria J ^a   Piris, Miguel A ^a,d   Rodríguez Peralto, José L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; OSTEOPONTIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; DNA TRANSCRIPTION; EPITHELIUM CELL; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MESENCHYME CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MESODERM; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MESODERM; MIDDLE AGED; SKIN NEOPLASMS;

EID: 34248223535     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3481     Document Type: Article

References (50)

1. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-72.
2. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 2000;406:536-40.
3. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004;64: 5270-82.
4. McGill GG, Horstmann M, Widlund HR, et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002;109:707-18.
5. Haqq C, Nosrati M, Sudilovsky D, et al. The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A 2005;102:6092-7.
6. Winnepenninckx V, Lazar V, Michiels S, et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 2006;98: 472-82.
7. Talantov D, Mazumder A, Yu JX, et al. Novel genes associated with malignant melanoma but not benign melanocyte lesions. Clin Cancer Res 2005;11:7234-42.
8. Retsas S, Henry K, Mohammed MQ, et al. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer 2002;38:511-6.
9. Alonso SR, Ortiz P, Pollan M, et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 2004;164:193-203.
10. Rimm DL, Camp RL, Charette LA, et al. Tissue microarray: a new technology for amplification of tissue resources. Cancer J 2001;7:24-31.
11. Eberwine J. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. Biotechniques 1996;20:584-91.
12. Tracey L, Villuendas R, Ortiz P, et al. Identification of genes involved in resistance to interferon-α in cutaneous T-cell lymphoma. Am J Pathol 2002;161:1825-37.
13. Benjamini Y, Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics 2005; 171:783-90.
14. Fernandez-Peralta AM, Nejda N, Oliart S, et al. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability. Cancer Genet Cytogenet 2005;157:18-24.
15. Fujita M, Furukawa Y, Tsunoda T, et al. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the β-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res 2001;61: 7722-6.
16. Wrobel G, Roerig P, Kokocinski F, et al. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 2005; 114:249-56.
17. Nakatsura T, Kageshita T, Ito S, et al. Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 2004;10:6612-21.
18. Samanna V, Wei H, Ego-Osuala D, et al. α-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Exp Cell Res 2006;312:2214-30.
19. Zhou Y, Dai DL, Martinka M, et al. Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 2005;124:1044-52.
20. Pass HI, Lott D, Lonardo F, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005;353:1564-73.
21. Chen X, Higgins J, Cheung ST, et al. Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 2004;17:1198-210.
22. Kato Y, Lewalle JM, Baba Y, et al. Induction of SPARC by VEGF in human vascular endothelial cells. Biochem Biophys Res Commun 2001;287:422-6.
23. Gruber JR, Desai S, Blusztajn JK, et al. Retinoic acid specifically increases nuclear PKC α and stimulates AP-1 transcriptional activity in B16 mouse melanoma cells. Exp Cell Res 1995;221:377-84.
24. Timar J, Liu B, Bazaz R, et al. Association of protein kinase-C-α with cytoplasmic vesicles in melanoma cells. J Histochem Cytochem 1996;44:177-82.
25. Lahav R, Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma. Int J Dev Biol 2005;49:173-80.
26. Lahn MM, Sundell KL. The role of protein kinase C-α (PKC-α) in melanoma. Melanoma Res 2004;14: 85-9.
27. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003;4:657-65.
28. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002;21:3241-6.
29. Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-4.
30. Hendrix MJ, Seftor EA, Kirschmann DA, et al. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 2003;995: 151-61.
31. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999;18:345-57.
32. Hazan RB, Phillips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148:779-90.
33. Shimoyama Y, Tsujimoto G, Kitajima M, et al. Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J 2000; 349:159-67.
34. Hsu MY, Meier FE, Nesbit M, et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000;156:1515-25.
35. Hsu MY, Wheelock MJ, Johnson KR, et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc 1996;1: 188-94.
36. Gallego Attis M, Burchette JL, Angelica Selim M, et al. Differential expression of N-cadherin distinguishes aggressive spindle cell melanomas from desmoplastic melanomas. Am J Dermatopathol 2006;28:232.
37. Krengel S, Groteluschen F, Bartsch S, et al. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J Cutan Pathol 2004;31:1-7.
38. Jendraschak E, Sage EH. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin Cancer Biol 1996;7:139-46.
39. Rumpler G, Becker B, Hafner C, et al. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol 2003;12:761-71.
40. Ledda F, Bravo AI, Adris S, et al. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 1997; 108:210-4.
41. Geissinger E, Weisser C, Fischer P, et al. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res 2002;62:4820-8.
42. Oka M, Kikkawa U. Protein kinase C in melanoma. Cancer Metastasis Rev 2005;24:287-300.
43. Szalay J, Bruno P, Bhati R, et al. Associations of PKC isoforms with the cytoskeleton of B16F10 melanoma cells. J Histochem Cytochem 2001;49:49-66.
44. Dennis JU, Dean NM, Bennett CF, et al. Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α. Cancer Lett 1998:128:65-70.
45. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 2004; 164:651-63.
46. Ping Lu Y, Ishiwata T, Asano G. Lumican expression in α cells of islets in pancreas and pancreatic cancer cells. J Pathol 2002;196:324-30.
47. Naito Z, Ishiwata T, Kurban G, et al. Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int J Oncol 2002;20:943-8.
48. Kageshita T, Hamby CV, Hirai S, et al. α(v)β3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis. Cancer Immunol Immunother 2000;49:314-8.
49. Redondo P, Lloret P, Idoate M, et al. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol 2005;30:541-5.
50. Teti A, De Giorgi A, Spinella MT, et al. Transforming growth factor-β enhances adhesion of melanoma cells to the endothelium in vitro. Int J Cancer 1997;72:1013-20.